Skip to main content
. 2017 Dec 17;9(3):3779–3793. doi: 10.18632/oncotarget.23375

Table 2. Characteristics of clones obtained by CRISPR/Cas9 mediated ATM inactivation in the mother’s fibroblasts.

Clone Cas9 induced mutagenesis Genotype
On WT allele On R32C allele
#1 None None R32C/WT
#2 None None R32C/WT
#11 37bp deletion None –/WT
#14 None Allele not amplified R32C/–